Man Group PLC Heron Therapeutics, Inc. Transaction History

Man Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $98,899 - $270,470	-43,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $199,090 - $427,420	43,000 New	43,000 $246,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $4.31 Million - $5.6 Million	-315,161 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $3.43 Million - $6.77 Million	315,161 New	315,161 $4.64 Million
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $1.67 Million - $4.01 Million	-163,328 Closed	0 $0

Q4 2019 Feb 18, 2020	BUY	$17.42 - $26.61 $2.85 Million - $4.35 Million	163,328 New	163,328 $3.84 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $475,028 - $621,080	-29,036 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $254,017 - $393,404	-15,004 Reduced 34.07%	29,036 $540,000
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $387,577 - $474,468	-16,742 Reduced 27.54%	44,040 $1.08 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $1.34 Million - $1.95 Million	60,782 New	60,782 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $552,960 - $752,947	-18,432 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $486,604 - $774,144	18,432 New	18,432 $716,000

169

119M

151K

103K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $439M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.